ArticleQuantitative imaging in medicine and surgery2026
A curriculum-guided unified framework for robust unsupervised domain adaptation on multi-cohort Parkinson's disease diagnosis.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current artificial intelligence (AI) models for Parkinson's disease (PD) diagnosis via magnetic resonance imaging (MRI) are significantly impeded by domain shift, and performance often decreases due to heterogeneity in imaging protocols and scanners across hospitals. While existing unsupervised domain adaptation (UDA) methods combining self-training and adversarial training enhance model generalizability, their dependence on pseudo-labels often introduces confirmation bias from noisy predictions. This study aimed to mitigate pseudo-label noise, enhance domain-invariant feature learning and develop a novel UDA framework for robust cross-center PD diagnosis. Methods: We propose a curriculum-guided unified UDA (CGU-UDA) framework that integrates self-training and adversarial training. Its core innovation is a feedback loop between adaptive pseudo-label refinement and contextual feature regularization. First, a curriculum learning scheduler dynamically adjusts confidence thresholds per class based on real-time learning progress and progressively filters high-quality pseudo-labels. Second, a consistency constraint module enforces prediction agreement between original target images and their randomly masked image and leverages these refined labels to promote robust, context-aware feature learning. Finally, an adversarial domain discriminator conditioned on a randomized multilinear map is applied to align feature distributions across domains. Results: Evaluations on two independent multi-cohort PD MRI datasets show that CGU-UDA consistently surpasses leading UDA benchmarks. It achieves an average increase of over 2% in classification accuracy and over 3% in area under the curve (AUC) across varied cross-domain tasks. On Hospital→Parkinson's Progression Markers Initiative (PPMI), accuracy improved from 65.81% of baseline to 67.95%, AUC from 0.6474 to 0.7148; on PPMI→Hospital, accuracy improved from 63.83% to 65.96%, AUC from 0.6324 to 0.6687. Ablation studies confirm that both the dynamic thresholding mechanism and the masked consistency constraint are crucial to this performance gain. Conclusions: This work advances robust medical AI model by directly tackling the pseudo-label noise problem in domain adaptation. The CGU-UDA framework demonstrates strong potential for deploying reliable diagnostic models across diverse clinical settings and leading to effective clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.